Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema-Reference-Cited by-同舟云学术

Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema

Published:2018-08-26 Issue:10 Volume:48 Page:1325-1332
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Pawaskar Dipti¹,Tortorici Michael A.¹,Zuraw Bruce²^ORCID,Craig Timothy³,Cicardi Marco⁴,Longhurst Hilary⁵,Li H. Henry⁶,Lumry William R.⁷,Martinez-Saguer Inmaculada⁸,Jacobs Joshua⁹,Bernstein Jonathan A.¹⁰,Riedl Marc A.¹¹,Katelaris Constance H.¹²,Keith Paul K.¹³,Feussner Annette¹⁴,Sidhu Jagdev¹⁵

Affiliation:

1. CSL Behring; King of Prussia Pennsylvania

2. Department of Medicine; University of California San Diego and San Diego VA Healthcare; La Jolla California

3. Department of Medicine, Pediatrics and Graduate Studies; Penn State University; Hershey Pennsylvania

4. Dipartimento di Scienze Biomediche e Cliniche “L. Sacco”; Università Degli Studi Di Milano; Milan Italy

5. Addenbrookes Hospital; Cambridge Universities NHS Foundation Trust; Cambridge UK

6. Institute for Asthma and Allergy; Chevy Chase Maryland

7. AARA Research CenterAllergy and Asthma Specialists; Dallas Texas

8. Haemophilia Centre Rhine Main (HZRM); Moerfelden-Walldorf Germany

9. Allergy and Asthma Clinical Research Walnut Creek; Walnut Creek California

10. Department of Immunology/Allergy; University of Cincinnati College of Medicine and Bernstein Clinical Research Center; Cincinnati Ohio

11. Department of Medicine; Division of Rheumatology, Allergy & Immunology; University of California San Diego; San Diego California

12. Department of Medicine; Campbelltown Hospital; Western Sydney University; Sydney New South Wales Australia

13. Department of Medicine; McMaster University; Hamilton Ontario Canada

14. CSL Behring; Marburg Germany

15. CSL Limited; Parkville Melbourne Australia

Funder

CSL Behring

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.13220/fullpdf

Reference28 articles.

1. C1 inhibitor and hereditary angioneurotic edema;Davis;Ann Rev Immunol,1988

2. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients;Agostoni;Medicine,1992

3. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group;Cicardi;Allergy,2014

4. Hereditary angioedema: the clinical syndrome and its management;Frank;Ann Internal Med,1976

5. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress;Cugno;Trends Mol Med,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berotralstat in hereditary angioedema due to C1 inhibitor deficiency: first real-world evidence from a Canadian center;Frontiers in Immunology;2024-01-22

2. Hereditary Angioedema Management: From Dealing to Leading;EMJ Allergy & Immunology;2022-08-11

3. Angioedema with severe acute abdominal pain: Think of hereditary angioedema;Clinics and Research in Hepatology and Gastroenterology;2021-07

4. Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review;Allergy, Asthma & Clinical Immunology;2020-05-27

5. A focus on the use of subcutaneous C1-inhibitor for treatment of hereditary angioedema;Expert Review of Clinical Immunology;2020-04-06